{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:31:42Z","timestamp":1777329102991,"version":"3.51.4"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pancreas"],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>Large biobanks with uniform collection of biomaterials and associated clinical data are essential for translational research. The Netherlands has traditionally been well organized in multicenter clinical research on pancreatic diseases, including the nationwide multidisciplinary Dutch Pancreatic Cancer Group and Dutch Pancreatitis Study Group. To enable high-quality translational research on pancreatic and periampullary diseases, these groups established the Dutch Pancreas Biobank.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The Dutch Pancreas Biobank is part of the Parelsnoer Institute and involves all 8 Dutch university medical centers and 5 nonacademic hospitals. Adult patients undergoing pancreatic surgery (all indications) are eligible for inclusion. Preoperative blood samples, tumor tissue from resected specimens, pancreatic cyst fluid, and follow-up blood samples are collected. Clinical parameters are collected in conjunction with the mandatory Dutch Pancreatic Cancer Audit.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Between January 2015 and May 2017, 488 patients were included in the first 5 participating centers: 4 university medical centers and 1 nonacademic hospital. Over 2500 samples were collected: 1308 preoperative blood samples, 864 tissue samples, and 366 follow-up blood samples.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Prospective collection of biomaterials and associated clinical data has started in the Dutch Pancreas Biobank. Subsequent translational research will aim to improve treatment decisions based on disease characteristics.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mpa.0000000000001018","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T01:05:08Z","timestamp":1520557508000},"page":"495-501","source":"Crossref","is-referenced-by-count":10,"title":["The Dutch Pancreas Biobank Within the Parelsnoer Institute"],"prefix":"10.1097","volume":"47","author":[{"given":"Marin","family":"Strijker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arja","family":"Gerritsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jony","family":"van Hilst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten F.","family":"Bijlsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bert A.","family":"Bonsing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lodewijk A.","family":"Brosens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco J.","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald M.","family":"van Dam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederike","family":"Dijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casper H.","family":"van Eijck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arantza","family":"Farina Sarasqueta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Fockens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael F.","family":"Gerhards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bas","family":"Groot Koerkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwin","family":"van der Harst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignace H.","family":"de Hingh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanin E.","family":"van Hooft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9ment J.","family":"Huysentruyt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"Kazemier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost M.","family":"Klaase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis J.","family":"van Laarhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanneke W.","family":"van Laarhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike S.","family":"Liem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent E.","family":"de Meijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Bengt","family":"van Rijssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hjalmar C.","family":"van Santvoort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Suker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith H.","family":"Verhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Verheij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hein W.","family":"Verspaget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roos A.","family":"Wennink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna W.","family":"Wilmink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. Quintus","family":"Molenaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marja A.","family":"Boermeester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier R.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc G.","family":"Besselink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20231016","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"bib2-20231016","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.1200\/JCO.2009.21.9022","article-title":"Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment","volume":"27","year":"2009","journal-title":"J Clin Oncol"},{"key":"bib3-20231016","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(16)32409-6","article-title":"Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial","volume":"389","year":"2017","journal-title":"Lancet"},{"key":"bib4-20231016","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","article-title":"Pancreatic cancer","volume":"378","year":"2011","journal-title":"Lancet"},{"key":"bib5-20231016","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer","volume":"364","year":"2011","journal-title":"N Engl J Med"},{"key":"bib6-20231016","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"key":"bib7-20231016","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1200\/JCO.2007.13.4403","article-title":"Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT","volume":"26","year":"2008","journal-title":"J Clin Oncol"},{"key":"bib8-20231016","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","year":"2010","journal-title":"Lancet"},{"key":"bib9-20231016","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1470-2045(16)00163-7","article-title":"5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial","volume":"17","year":"2016","journal-title":"Lancet Oncol"},{"key":"bib10-20231016","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.gastro.2015.08.056","article-title":"Genetic diversity of pancreatic ductal adenocarcinoma and opportunities for precision medicine","volume":"150","year":"2016","journal-title":"Gastroenterology"},{"key":"bib11-20231016","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","article-title":"Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group","volume":"25","year":"2007","journal-title":"J Clin Oncol"},{"key":"bib12-20231016","first-page":"117","article-title":"Personalized therapy for pancreatic cancer: Do we need better targets, arrows, or both?","volume":"21","year":"2016","journal-title":"Discov Med"},{"key":"bib13-20231016","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MPA.0000000000000385","article-title":"Advances in molecular pathology and treatment of periampullary cancers","volume":"45","year":"2016","journal-title":"Pancreas"},{"issue":"suppl 15","key":"bib14-20231016","article-title":"Adjuvant capecitabine for biliary tract cancer: The BILCAP randomized study. 2017 ASCO Annual Meeting","volume":"35","year":"2017","journal-title":"J Clin Oncol"},{"key":"bib15-20231016","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1245\/s10434-014-4267-4","article-title":"Histological and molecular subclassification of pancreatic and nonpancreatic periampullary cancers: implications for (neo) adjuvant systemic treatment","volume":"22","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"bib16-20231016","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.2013.279201","article-title":"Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"bib17-20231016","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0140-6736(16)00097-0","article-title":"Chronic pancreatitis","volume":"387","year":"2016","journal-title":"Lancet"},{"key":"bib18-20231016","first-page":"503109","article-title":"Surgical approaches to chronic pancreatitis","volume":"2015","year":"2015","journal-title":"Gastroenterol Res Pract"},{"key":"bib19-20231016","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4291\/wjgp.v5.i4.427","article-title":"Genetics of acute and chronic pancreatitis: an update","volume":"5","year":"2014","journal-title":"World J Gastrointest Pathophysiol"},{"key":"bib20-20231016","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.disamonth.2014.11.002","article-title":"Chronic pancreatitis, a comprehensive review and update. Part I: epidemiology, etiology, risk factors, genetics, pathophysiology, and clinical features","volume":"60","year":"2014","journal-title":"Dis Mon"},{"key":"bib21-20231016","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.3748\/wjg.v20.i24.7849","article-title":"Personalising pancreas cancer treatment: when tissue is the issue","volume":"20","year":"2014","journal-title":"World J Gastroenterol"},{"key":"bib22-20231016","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.2217\/fon-2016-0243","article-title":"Pancreatic cancer tissue banks: where are we heading?","volume":"12","year":"2016","journal-title":"Future Oncol"},{"key":"bib23-20231016","article-title":"The Parelsnoer Institute: a national network of standardized clinical biobanks in the Netherlands","volume":"4","year":"2017","journal-title":"Open J Bioresour"},{"key":"bib24-20231016","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/ndt\/gft307","article-title":"The Biobank of Nephrological Diseases in the Netherlands cohort: the String of Pearls Initiative collaboration on chronic kidney disease in the university medical centers in the Netherlands","volume":"29","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"bib25-20231016","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/dote.12347","article-title":"Esophageal and Gastric Cancer Pearl: a nationwide clinical biobanking project in the Netherlands","volume":"29","year":"2016","journal-title":"Dis Esophagus"},{"key":"bib26-20231016","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/ijs.12359","article-title":"The Dutch String-of-Pearls Stroke Study: protocol of a large prospective multicenter genetic cohort study","volume":"10","year":"2015","journal-title":"Int J Stroke"},{"key":"bib28-20231016","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.dld.2012.09.014","article-title":"Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium","volume":"45","year":"2013","journal-title":"Dig Liver Dis"},{"key":"bib30-20231016","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","year":"2017","journal-title":"Nature"},{"key":"bib31-20231016","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","year":"2016","journal-title":"Nature"},{"key":"bib32-20231016","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","year":"2015","journal-title":"Nature"},{"key":"bib33-20231016","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature11547","article-title":"Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes","volume":"491","year":"2012","journal-title":"Nature"},{"key":"bib36-20231016","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12967-015-0469-1","article-title":"Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract","volume":"13","year":"2015","journal-title":"J Transl Med"},{"key":"bib37-20231016","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13000-016-0497-z","article-title":"Surgical and molecular pathology of pancreatic neoplasms","volume":"11","year":"2016","journal-title":"Diagn Pathol"},{"key":"bib38-20231016","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.path.2016.05.003","article-title":"Pancreatic ductal adenocarcinoma and its variants","volume":"9","year":"2016","journal-title":"Surg Pathol Clin"},{"key":"bib39-20231016","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pan.2016.02.004","article-title":"Morphological heterogeneity in ductal adenocarcinoma of the pancreas - Does it matter?","volume":"16","year":"2016","journal-title":"Pancreatology"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006676-201804000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T03:34:50Z","timestamp":1697427290000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006676-201804000-00020"}},"subtitle":["A Nationwide Biobank of Pancreatic and Periampullary Diseases"],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000001018","relation":{},"ISSN":["1536-4828","0885-3177"],"issn-type":[{"value":"1536-4828","type":"electronic"},{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}